{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-26-000052","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2026-05-15T11:59:42+00:00","discovered_at":"2026-05-15T12:05:00.218088+00:00","generated_at":"2026-05-15T12:07:44.402522+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Tandem Diabetes terminates CCO Mark Novara without cause; last day May 18","bullets":["Mark Novara, EVP & Chief Commercial Officer, notified of termination without cause on May 11, 2026.","His last day of employment is scheduled to be May 18, 2026.","Company states its strategy and 2026 goals remain unchanged.","No successor has been announced as of the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-26-000052","json":"https://secwatch.observer/filing/0001438133-26-000052.json","markdown":"https://secwatch.observer/filing/0001438133-26-000052.md","text":"https://secwatch.observer/filing/0001438133-26-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000052/0001438133-26-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000052/tndm-20260511.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:07:44.402522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8bb1da9db4","claim":"Mark Novara was terminated as Executive Vice President and Chief Commercial Officer at TANDEM DIABETES CARE INC.","evidence_excerpt":"On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1438133/000143813326000052/0001438133-26-000052-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Vice President and Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}